Contributors
Latest:
Two-Drug Combo Improves Post-Transplant Myeloma OutcomesA two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.
Latest:
Defining Cancer SurvivorshipWhen does a patient become a survivor of cancer? Some believe it’s at the moment of diagnosis, but others disagree.
Latest:
Every Time I Think I Have CancerYou know that saying “when you are sick, the internet is not your friend”? Well, that’s a fact. I start looking up runny nose, and because I believe that the runny substance coming from my nose must be spinal fluid, I must have brain cancer.
Latest:
Journaling Through ConfinementAn author who journaled while homebound after cancer treatment has created a book of writing prompts for those who are staying put during the COVID-19 pandemic.
Latest:
Nanotechnology-Enabled Cancer Treatments and DiagnosticsThe National Cancer Institute launched its Alliance for Nanotechnology in Cancer with the goal of using nanomedicine to change the way cancer is treated.
Latest:
Front-Line Imbruvica-Venclexta Combo May Induce Durable Responses in Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaTreatment with this combination was associated with encouraging clinical responses in this patient population.
Latest:
The Administration's Drug Rebate Proposal: An Opportunity to Put Patients FirstOf all the health care regulations coming out of the current administration, the recent drug rebate proposal presents a new opportunity to significantly lower out-of-pocket prescription drug costs for Medicare patients. But like most things in health care, there is more complexity to the administration’s proposed changes to pharmaceutical company rebates than initially meets the eye.
Latest:
Examining the Safety of CLL MedicationOVER THE LAST FEW years, significant advances were made in the treatment of patients with chronic lymphocytic leukemia (CLL). Several novel therapies, most of them oral, have now been approved by the Food and Drug Administration. These include Imbruvica (ibrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor; Venclexta (venetoclax), a B-cell lymphoma-2 (BCL2) inhibitor; and Zydelig (idelalisib), a phosphoinositide 3-kinase (PI3K) inhibitor.
Latest:
The Importance of Biomarker Testing for Patients and Their FamiliesUnderstanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.
Latest:
One Million and Counting ... in Support of Bladder Cancer ResearchWhen my late husband John and I started the Bladder Cancer Advocacy Network (BCAN) in 2005, our goal was not only to raise awareness about bladder cancer, but to change the landscape for this disease by funding research to discover new treatments that will save lives.
Latest:
Web Tools Help Men Deal with Side Effects of Cancer TreatmentAn online tool is designed to help men with prostate or other types of cancer deal with sexual dysfunction and other common side effects of treatment.
Latest:
Looking At Yourself Differently After CancerMoment by moment, we move toward life. We feel what needs to be felt. We can even feel through the numb parts—the broken pieces. Instead of looking somewhere else, we look straight on— at ourselves and others. We see what’s really there. Who is there for us? Who is not? We choose to be with those we love, and those who love us back—like the person in the mirror, the new friend.
Latest:
'CURE Expert Connections' Launches 'An Opportunity for Treatment in Relapsed Hairy Cell Leukemia' Video SeriesA patient and a physician discuss the treatment landscape of hairy cell.
Latest:
Born to Love and Serve"There is a special class of nurse that exceeds all expectations, a nurse who embodies these characteristics as part of the very fabric of who she is as a human being, one who seemingly was born to love and serve, and that is where you can find Darcy Doege, B.S.N., RN,” wrote Mellisa Wheeler, M.H.A., B.S.W., Atrium Health’s Levine Cancer Institute.
Latest:
MJH Life Sciences Launches Medical World NewsMJH Life Sciences™ has officially launched Medical World News®, a first-of-its-kind 24-hour news program.
Latest:
A Watershed Moment for EAO-CRC: ACS Drops Screening Age to 45It was the drop heard 'round the colorectal cancer world.
Latest:
From Devastation to InspirationAn Extraordinary Healer essay honoring PROFESSIONALS OF THE GYNECOLOGIC ONCOLOGY UNIT [KAISER PERMANENTE MEDICAL CENTER, LOS ANGELES, CALIFORNIA]
Latest:
Preserving Fertility and Improving Outcomes in Breast CancerHalle Moore, M.D., physician at Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, discusses fertility preservation in women with breast cancer.
Latest:
What Patients With Tenosynovial Giant Cell Tumors Should Know About TuralioThe Food and Drug Administration’s approval of Turalio for tenosynovial giant cell tumors may offer significantly improved clinical benefit for select patients with these rare, benign tumors.
Latest:
Hopes for the Future of Cancer CareJeff Allen, president and CEO of Friends of Cancer Research, shares what he hopes continuing advancements and the Cancer Moonshot will achieve in cancer care.
Latest:
The Benefits of Falun Gong for Patients With CancerYuhong Dong, M.D., PhD, clinical researcher at Novartis, discusses the benefits of Falun Gong, a Chinese mind-body practice, for patients with cancer.
Latest:
Patients with Multiple Myeloma Give Themselves Hope Through TreatmentDr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.
Latest:
Inaugural CURE, Canadian Edition Editor's Note: Hello, Canada!WHEN WE STARTED TALKING about the idea of a magazine focused on cancer for Canadians more than a year ago, we had a vision.
Latest:
Two Lost People and an AngelThis essay was written by Maria Campos nominating Mary Kernan, RN, OCN, of Smilow Cancer Center At Yale New Haven Health, New Haven, Connecticut, for CURE®'s Extraordinary Healer® Award.
Latest:
Kim Statham Ringen on the Importance of Meeting Other SurvivorsKim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Latest:
A New Line of Defense in Blood Cancer: Natural Killer Cell TherapyNatural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.
